Reaction Details |
| Report a problem with these data |
Target | Nuclear receptor subfamily 4 group A member 2 |
---|
Ligand | BDBM50517826 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1869814 (CHEMBL4370880) |
---|
EC50 | 1.000000±n/a nM |
---|
Citation | Lesuisse, D; Malanda, A; Peyronel, JF; Evanno, Y; Lardenois, P; De-Peretti, D; Abécassis, PY; Barnéoud, P; Brunel, P; Burgevin, MC; Cegarra, C; Auger, F; Dommergue, A; Lafon, C; Even, L; Tsi, J; Luc, TPH; Almario, A; Olivier, A; Castel, MN; Taupin, V; Rooney, T; Vigé, X Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease. Bioorg Med Chem Lett29:929-932 (2019) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Nuclear receptor subfamily 4 group A member 2 |
---|
Name: | Nuclear receptor subfamily 4 group A member 2 |
Synonyms: | NR4A2_MOUSE | NUR-related factor 1 | Nr4a2 | Nuclear receptor subfamily 4 group A member 2 | Nurr1 | Orphan nuclear receptor NURR1 |
Type: | PROTEIN |
Mol. Mass.: | 66605.74 |
Organism: | Mus musculus |
Description: | ChEMBL_116964 |
Residue: | 598 |
Sequence: | MPCVQAQYGSSPQGASPASQSYSYHSSGEYSSDFLTPEFVKFSMDLTNTEITATTSLPSF
STFMDNYSTGYDVKPPCLYQMPLSGQQSSIKVEDIQMHNYQQHSHLPPQSEEMMPHSGSV
YYKPSSPPTPSTPSFQVQHSPMWDDPGSLHNFHQNYVATTHMIEQRKTPVSRLSLFSFKQ
SPPGTPVSSCQMRFDGPLHVPMNPEPAGSHHVVDGQTFAVPNPIRKPASMGFPGLQIGHA
SQLLDTQVPSPPSRGSPSNEGLCAVCGDNAACQHYGVRTCEGCKGFFKRTVQKNAKYVCL
ANKNCPVDKRRRNRCQYCRFQKCLAVGMVKEVVRTDSLKGRRGRLPSKPKSPQDPSPPSP
PVSLISALVRAHVDSNPAMTSLDYSRFQANPDYQMSGDDTQHIQQFYDLLTGSMEIIRGW
AEKIPGFADLPKADQDLLFESAFLELFVLRLAYRSNPVEGKLIFCNGVVLHRLQCVRGFG
EWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTERHGLKEPKRVEELQNKIVNCLKDHVT
FNNGGLNRPNYLSKLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPAIIDKLFLDTLPF
|
|
|
BDBM50517826 |
---|
n/a |
---|
Name | BDBM50517826 |
Synonyms: | CHEMBL4453191 |
Type | Small organic molecule |
Emp. Form. | C19H12F2N4O |
Mol. Mass. | 350.3216 |
SMILES | Fc1ccc(F)c(NC(=O)c2cn3cc(ccc3n2)-c2ccccn2)c1 |
Structure |
|